The Latest Breaking News from FDA

WHO classifies aspartame as potential carcinogen, despite limited evidence; FDA disputes findings

F1 young driver programmes take drivers in lower tiers and trains them to be F1 drivers, but which drivers are in them and which teams do they belong to?

The recently approved contraception Opill should be available for consumers next year. It's not clear how or whether insurance will cover it. Here's what's known so far.

The Food and Drug Administration’s July 13, 2023, approval of the first over-the-counter birth control pill, called Opill, broadens the options for people seeking to prevent pregnancy. When Opill becomes available, presumably in the first quarter of 2024, it will be sold in grocery and convenience stores, in pharmacies and…

The U.S. Food and Drug Administration issued its most serious type of recall for 348,616 Medtronic defibrillators, saying they are at risk for delivering "a reduced-energy shock or not shock at all," which could lead to cardiac arrest for a patient.

NRx's NRX-101 shows promise in clinical trials, aims for FDA approval in 2024 to address unmet medical need.

Previous studies show these products contain ingredients such as steroids and mercury that could be harmful to the skin

Beyfortus should be available this fall and can prevent a disease that kills around 300 children per year

As the U.S. struggles with prescription drug shortages, South Dakota Gov. Kristi Noem has advanced a modest plan that she hopes will prod Washington to address weaknesses in the international pharmaceutical supply chain